Loading…
avatar for Patrick Frey

Patrick Frey

FDA
Chief of Staff, Office of New Drugs, CDER
Patrick Frey is the Chief of Staff in CDER's Office of New Drugs. He has played leadership roles in the reauthorization of PDUFA V and VI as well as BSUFA II. He was also the CDER lead in developing and implementing CDER's structured framework for benefit-risk assessment. Patrick obtained his Masters in Public Policy from the University of Michigan.